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Abstract
Background: The adaptation of unicellular organisms like Saccharomyces cerevisiae to alternating nutrient
availability is of great fundamental and applied interest, as understanding how eukaryotic cells respond to
variations in their nutrient supply has implications spanning from physiological insights to biotechnological
applications.
Results: The impact of a step-wise restricted supply of phosphate on the physiological state of S. cerevisiae cells
producing human Insulin was studied. The focus was to determine the changes within the global gene expression
of cells being cultured to an industrially relevant high cell density of 33 g/l cell dry weight and under six distinct
phosphate concentrations, ranging from 33 mM (unlimited) to 2.6 mM (limited). An increased flux through the
secretory pathway, being induced by the PHO circuit during low Pi supplementation, proved to enhance the
secretory production of the heterologous protein. The re-distribution of the carbon flux from biomass formation
towards increased glycerol production under low phosphate led to increased transcript levels of the insulin gene,
which was under the regulation of the TPI1 promoter.
Conclusions: Our study underlines the dynamic character of adaptive responses of cells towards a change in their
nutrient access. The gradual decrease of the phosphate supply resulted in a step-wise modulated phenotypic
response, thereby alternating the specific productivity and the secretory flux. Our work emphasizes the importance
of reduced phosphate supply for improved secretory production of heterologous proteins.
Keywords: Phosphate regulation, heterologous protein production, chemostat cultivations, human insulin, secre-
tory flux, TPI1 promoter
Background
The long traditional attention and thus gathered famil-
iarity with Saccharomyces cerevisiae is grounded on the
deep knowledge about its genetics, physiology and culti-
vation techniques, making this eukaryote the main
workhorse to study essential biological phenomena.
Clearly, the gain of such immense knowledge fruited in
many commercial success stories, when the formerly
underrated baker’s or brewer’s yeast matured to one of
the most widely used hosts for a large portfolio of pro-
ducts derived by means of recombinant DNA technol-
ogy. Regarding its revenue and market, the production
of active pharmaceutical ingredients (APIs) represents
currently with annual global sales of approx. US$ 100
billion (reviewed by [1]), a significant field of research
for improved yeast cell factory design.
The biotechnological production of human Insulin in
S. cerevisiae (comprehensively reviewed by [2]) is con-
sidered to be the first of such successful commercial
achievements, and represents even today, due to its
enormous medical and market value, a highly important
field of research. Despite the recent developments
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within the field of metabolic engineering and synthetic
biology, which mostly target the production of metabo-
lites like organic acids [3] and the reinforced alternatives
to former petrochemical-based compounds (reviewed by
[4] and [5]), only little novel engineering has been
achieved in yeast with respect to its secretory abilities.
Strain engineering approaches towards enhanced secre-
tory production of APIs remain essentially on the levels
of target gene amplification, over-expression of few ER-
associated foldases [6], and the engineering of modified
secretion signals that supposedly aim at optimizing the
trafficking and release of the heterologous package
(reviewed by [7]). The secretory machinery of eukaryotes
like S. cerevisiae, embodying its severe quality control
abilities and the performance of complex posttransla-
tional modifications, is still providing a partly undiscov-
ered and thus fruitful ground for biotechnological
progress with respect to both quantitatively and qualita-
tively enhanced production of APIs. In particular, the
popular metabolic engineering philosophy of channeling
an increased flux towards a given metabolic pathway
turns out to be more challenging when it comes to
increasing the secretory flux of the cells, as engineering
of yeast protein factories still remains on the level of
chaperone and ER resident folding catalysts (reviewed
by [8])
One of the key elements for optimized production of
APIs has traditionally been the design and deployment
of growth media in which the cells are provided with
excess nutrients to grow, multiply, and to produce the
protein of interest. Such nutritious media support first
of all the growth of the recombinant cells, compensating
the additional burden derived from the over-production
of the heterologous protein. But, could the excess supply
of nutrients potentially saturate, and thus partly silence,
biosynthetic and reshuffling processes of key API pre-
cursors? And would these processes, when stimulated
under nutrient hunger, improve the processing, e.g.
maturation and secretion of the protein of interest?
Growth under nutrient limited conditions has been
investigated in many cases during the past, facilitating
advanced physiological characterization of the cells. We
learned that by throttling the evolutionary favored bio-
mass formation, the salvaged energy and metabolic pre-
cursors can be re-distributed towards a particular
biosynthetic process, leading to the development of
novel bioprocessing strategies based on limited nutrient
supply, e.g. fed batch and continuous cultivations. As a
matter of fact, the yeast S. cerevisiae has great capabil-
ities of responding to alternations in its nutrient avail-
ability. As a unicellular system, it has evolutionary
matured measures to quickly respond to any changes in
its environment, and it does so through re-distribution
of energy and biosynthetic fluxes.
Inorganic phosphate (Pi) is an essential nutrient for
any organism, as it is required for the biosynthesis of
nucleotides, phospholipids and metabolites, in energy
metabolism, and it acts as an important messenger in
signal transduction processes. Sophisticated and efficient
regulatory circuits are needed for proper management
of mechanisms like acquisition, storage, and utilization
of phosphate. Recent studies have examined the impact
of limiting nutrient availability, e.g. C-, N-, P-, and S-
limitation, on a global scale of endo-metabolome [9],
proteome [10], transcriptome [11], or in combination
[12], to name a few. These studies (and references
herein) revealed close interconnection among the global
transcriptome and the specific growth rate, and further
highlighted the major physiological impact of carbon
limitation compared to the limitation of other nutrients,
e.g. nitrogen, phosphor and sulfur.
Yet, we suspect that the adaptive response of cells
towards a change in their nutrient access is a dynamic
process, meaning that cellular regulatory events do not
necessarily happen at the point of any particular limita-
tion, but follow a more transient progression from one
physiological bottleneck to the other. The understanding
of such regulatory events necessitates, besides to the
perception of physiological changes at limiting levels of
a given nutrient, also the observation of the progressive
changes during a step-wise reduced supply of that parti-
cular nutrient. In this study, we followed the transcrip-
tional impact of a step-wise reduced supply of
phosphate to cells that were growing under carbon lim-
ited condition in chemostat cultivations. As all our
investigated S. cerevisiae cultures were growing with
essentially the same fixed specific growth rate, i.e. being
fed by a controlled and limited supply of carbon, any
cellular response being not related to the alternating
phosphate supply was out-normalized. Besides, we put,
to our knowledge for the first time, the impact of a vari-
able phosphate supply in a context of the production of
a heterologous protein, in our case a human Insulin
Analogue Precursor (IAP), in S. cerevisiae. Yet another
novelty of our work is the fact that we examined the
cells in a more industrially relevant context than it is
generally done in nutrient limitation studies. The culti-
vations of the cells were performed at high cell density
in sophisticated continuous chemostat cultivations and
the analysis were carried out under steady state condi-
tions, increasing the quality of the obtained biological
insights. The S. cerevisiae cultures in this study grew at
10 fold higher glucose levels in the feed supply as com-
pared to standard laboratory practice, resulting in
reduced P/C ratios (phosphate to glucose ratio) and
thus lower residual phosphate levels.
To address the impact of low Pi on the physiological
state of S. cerevisiae in a more progressive manner, we
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carried out individual cultivations at six distinct phos-
phate supplies, chosen to cover the range from excess to
limiting levels. We monitored general physiological
changes, in terms of biomass formation, major exo-
metabolite secretion, and insulin production, in relation
to a diminishing phosphate supply. We followed the glo-
bal transcriptome as a function of supplied Pi in two
complementary ways: in a rigid way, based on a differ-
ential expression analysis (DEA) approach among cul-
tures growing under high versus low Pi conditions, and
in a consecutive way, based on a significant profile ana-
lysis (SPA) approach following the progression of tran-
scriptional changes from carbon limited to phosphate
limited growth. Our data contribute to the fundamental
understanding of cellular responses that are induced
when S. cerevisiae cells sense a diminishing phosphate
supply. In addition, we emphasize the importance of
both the design of growth media with reduced phos-
phate levels and the choice of promoter for the expres-
sion of the recombinant gene, resulting in improved
production of the heterologous protein of choice.
Results
Initially, we investigated the impact of a reduced phos-
phate supply on the metabolism and, more impor-
tantly, on the IAP productivity. The aim was to
identify a physiologically feasible range of the supplied
phosphate (Pi) level. Based on the outcomes, a range
of interest was identified, and a comprehensive study
on the global impact of sequentially decreasing Pi was
designed. For identifying the impact of reduced Pi sup-
ply on IAP production, we chose to gradually wash-out
the Pi from the initial medium whilst maintaining the
specific growth rate of the cells, using a fixed dilution
rate in the chemostat set-up. The gradual decrease of
the feed supply rate (pump 1) was compensated by a
gradual increase of the feed rate of a medium lacking
any phosphate source (pump 2), thereby maintaining
the overall feed rate constant and equal to the effluent
flow (Figure 1A). The Pi wash-out was initialized after
keeping the culture for a minimum of five volume
exchanges at steady state conditions. The estimated Pi
levels in the culture were calculated, neglecting possi-
ble delays due to mixing time, as a relatively high stir-
rer speed was chosen (1000 rpm). Before reaching the
point of cell wash-out (absolute Pi limitation) in the
later stage of the process (after 200 h of cultivation,
data not shown), a clear impact of the reduced Pi sup-
ply to the IAP production and biomass formation was
found (Figure 1B). An enhanced IAP production was
observed at reduced Pi levels, although the overall
metabolism, displayed by the CO2 profile, seemed to
be only slightly affected.
Physiological characterization of the cells with respect to
the impact of Pi supply
To understand the cause of increased IAP production
on a more ample perspective, we ran six separate che-
mostat cultivations, supplying six distinct Pi concentra-
tions 33 mM, 22 mM, 14.7 mM, 9.6 mM, 5.5 mM, and
2.6 mM, respectively, thus covering the determined
range of interest derived from our initial experiment. All
six cultivations were analyzed for general exo-metabo-
lites, i.e. residual glucose, ethanol, glycerol and acetate,
as well as for the secreted amount of the target protein
(IAP), biomass (via OD600 and cell dry weight analysis),
and global gene expression levels (on oligonucleotide
microarrays). The respiratory activity of the cells (based
on the carbon dioxide production level) was monitored
on-line and used for steady state determination. Once
the cultures fulfilled and maintained steady state condi-
tions for 10 generations, a sampling regime of two sam-
ples per day was followed for 4-5 days. The resulting
samples were analyzed as described, and the corre-
sponding yields on biomass (production yields, yi/X) and
glucose (consumption yields, Yi/S) were determined (Fig-
ure 1C).
A first glance on the physiological observations pic-
tured major changes in the metabolism and IAP expres-
sion within the chosen range of phosphate supply. The
biomass formation yield (yX/S) did not show any signifi-
cant changes within the Pi range of 33 mM (0.424 ±
0.008 g/g) to 14.7 mM (0.421 ± 0.004 g/g). Also, no sig-
nificant changes in the glycerol and ethanol yields were
detected in this range (changes within the standard
deviation). Yet, a first increase of the IAP production
yield (yP/X) was noticeable, increasing 22.6%, from 1.93
± 0.08 mg/g (33 mM Pi) to 2.37 ± 0.04 mg/g (14.7 mM
Pi). When the supplied Pi level was further decreased to
9.6 mM, major metabolic shifts were observed, leading
to a re-distribution of the carbon flow from biomass for-
mation (YX/S decreased about 14.6% to 0.362 ± 0.004 g/
g glucose) towards both glycerol formation (YG/S =
0.615 ± 0.041 mM/M glucose) and ethanol formation
(YE/S = 0.287 ± 0.031 mM/M glucose), indicating a shift
from an initially respiratory to an appearing respiro-fer-
mentative metabolism. The IAP production yield further
increased to yP/X = 2.98 ± 0.09 mg/g and was thus 54%
higher than the initial yield at 33 mM Pi. The further
decrease of the Pi supply led to a major loss of biomass
yield, due to augmented by-product formation (Figure
1D). A new range of interest with respect to the follow-
ing transcriptome analysis was chosen, thus being
further narrowed down to the range of 22 mM to 9.6
mM phosphate supply, as this range showed an interest-
ing increase of IAP productivity without significant loss
of carbon flux towards by-product formation.
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Transcriptome analysis I: Differential Expression Analysis
(DEA) of [22 mM Pi] vs. [9.6 mM Pi]
We carried out a pair-wise comparison between the cul-
tures grown at 22 mM and 9.6 mM phosphate for
exploring the global transcriptional impact on cells
under low and high phosphate levels, respectively. We
identified 381 genes being significantly differentially
expressed (statistical significance, Benjamini & Hochberg
FDR adjusted p ≤ 0.05) in a comparison of cultures sup-
plied with 9.6 mM phosphate [9.6 mM] to the control
culture, being supplied with 22 mM phosphate [22
mM]. The majority of these genes (217) were up-regu-
lated in [9.6 mM]. A second significance trap (biological
significance) was set to further narrow down the genes
of interest, choosing a fold change cut-off of abs(FC) ≥
2, resulting in a decrease of significant differentially
expressed genes to 146 genes, of which 87 were up-
regulated in [9.6 mM]. Within the top ten genes being
up-regulated, we identified five phosphatases PHO3
(15.1-fold), PHM6 and PHM8 (17.6-fold and 9.4-fold),
PHO11 (6.5-fold), and HOR2 (4.6-fold), besides to the
permease GIT1 (17.8-fold) being highly expressed under
low Pi conditions. AGene Ontology (GO Slim) enrich-
ment analysis was performed and enriched categories
(Figure 2), which together represented the majority of
the identified genes being either up- or down-regulated,
Figure 1 Physiological impact of reduced phosphate supply in chemostat cultivations.A. Schematic set-up of the Pi wash-out experiment.
The gradual decrease of the feed supply rate (pump P1) was compensated by a gradual increase of the feed rate of a medium lacking any
phosphate source (DMM-P, pump P2). The overall dilution rate was thus kept constant, and the residual phosphate in the culture was washed
out. B. An overview on the impact of decreasing phosphate supply during the wash-out process. The insulin titers (IAP, blue circles) increased
when the phosphate supply was restricted (pump A, red dashed line). C. representation of the biomass yield (black, 0.13-0.43 g/g), IAP
productivity (blue, 0.196-0.392 mg/gh), glycerol yield (green, 0-0.615 mmol/mol), and ethanol yield (red, 0-12.68 mmol/mol), as a function of the
supplied phosphate level in individual cultures. All four parameters were normalized to a range of zero (min. values) to one (max. values). D.
radar plot representation of the biomass yield (green) and the corresponding IAP yield (blue).
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were identified. The enriched categories related to
vacuole re-organization and protein maturation and
transport were considered to be very interesting, as the
secretory production of the heterologous IAP was
expected to be positively affected by the up-regulation
of the genes involved in the secretory machinery and
the recycling compartment of the cells, presumably
leading to an increased protein processing capacity of
the cells. The third enriched category of carbohydrate
metabolism revealed a first indication that a cross-talk
between phosphate supply and glycolytic flux does exist.
As the recombinant insulin gene cassette was put under
the regulation of the constitutive TPI1 promoter, we
assumed another, possibly positive, effect of low Pi
Figure 2 A volcano plot representation of the differentially expressed genes in a pair-wise comparison of cultures growing at high
phosphate level [22 mM] to low phosphate level [9.6 mM]. The significance cut-off was set to a FDR of 0.05 (-log(adj.P.val ≥ 1.3), the
biological cut-off was set to a fold change of ± 2 fold (-1 ≥ logFC ≥ 1), the top 30 differentially expressed genes are labeled with their
corresponding gene ID, the absolute fold change of all genes are represented by the circle size, the five different color codes used represent
insignificant genes (grey), both biologically and statistically significant genes being up-regulated (red, B) and down-regulated (green, A) at [22
mM] Pi, statistically but not biologically significant genes being up-regulated (orange) and down-regulated (light green) at [22 mM] Pi,
respectively. A GO slim enrichment analysis of the gene sets A and B revealed the over-representation of the pictured GO terms within the gene
sets A and B (%), the group of genes with an unknown biological function for gene set A (26%) and gene set B (25%) was excluded from
further analysis.
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supply to IAP expression due to the choice of a glycoly-
tic promoter.
One drawback of such a stringent Differential Expres-
sion Analysis (DEA) approach is the risk of losing
potentially valuable information on co-regulated genes
and their inter-connection among distinct pathways. By
using statistical and biological cut-offs for separating the
wheat from the chaff in a biological sense, only pieces of
a big regulatory picture are revealed, mostly due to the
fact that different steps in a given metabolic pathway
can be more or less transcriptionally regulated, depend-
ing on the complexity of the encoding enzymes. As
shown in (Figure 2), the sixth part in the lower right
part of the plot-representing genes which are highly up-
regulated in the high Pi supplied culture [22 mM], yet
which failed to pass the chosen statistical trap-encloses
significantly more genes as compared to the top right
sixth part. Also, the chosen biological cut-off led to a
non-observance of 65% of the statistically significant
genes (top middle sixth part), which potentially would
contribute to a more sophisticated biological mining of
the observed physiological state of the cells. This possi-
ble drawback was counteracted in a second approach,
where the focus was set to genes with a significant
expression profile as a function of supplied phosphate.
Additional insights to transcriptional changes via the
Significant Profile Analysis (SPA) approach
Our intention then was to salvage more in depth
insights into the impact of the altered phosphate supply
and its relation to insulin production. We suspected
that, by considering the expression pattern of any signif-
icant gene, and by identifying gene clusters which show
a progressive trend as a function of the change in their
phosphate availability, more in depth biological insights
regarding regulatory events can be found. For this, we
used a regression based methodology which is in more
common practice in time course experiments [13]. By
substituting the time factor with our compiled range of
interest for Pi concentration, the examined phosphate
levels were taken into account in a progressive manner.
However, we did not include data of the culture which
was supplied with the lowest Pi level [2.6 mM], as we
considered the physiological changes that occurred at
this level to be too abundant and not in favor of the
production of our target protein. Using the MicroArray
Significant Profiles (maSigPro) tool, 1289 genes were
identified which pictured a significant alternating
expression profile as a function of the supplied phos-
phate amount. These profiles were then separated in an
array of nine clusters and further sieved for similarity
with the more macroscopic determined trend of yP/X
(Figure 3A). We identified each two clusters of genes
with increasing (cB1 and cB2) and two clusters with
decreasing (cA1 and cA2) trend as a response to
decreasing Pi supply.
The clusters cA1 and cA2 showed a general similarity,
and more interestingly, no significant change in the
expression for the range of 33 mM to 14.7 mM Pi, reflect-
ing our previous observations with respect to the general
physiological state of the cells within this range. As com-
pared to the DEA results, and taking into account the
quantity of genes found in cA1 (283 genes) and cA2 (202
genes) picturing a significant profile, additional informa-
tion on down-regulated biological processes were found
with respect to a decreasing phosphate supply. The clus-
ters cB1 (115 genes) and cB2 (78 genes) constitute genes
which showed an increasing expression profile as a
response of decreasing Pi supply. Again, cluster cB1 shows
an interestingly high similarity to our physiological data, as
it represents genes with increased transcript levels when
the phosphate concentration is reduced to 9.6 mM and
below. In contrast, the genes encompassed within cluster
cB2 pictured a more sensitive response to the reduction of
phosphate in the corresponding cultures, as their expres-
sion changes throughout the entire range of examined Pi
supply. All four clusters where then surveyed for enriched
GO Slim categories, (Figure 3C.1 and 3C.2), representing
the majority (> 65%) of the comprising genes of the indivi-
dual clusters. Besides to the significantly enriched group of
gene with unknown biological process (> 20%) which was
excluded from the data mining, we identified GOs related
to protein maturation and transport being enriched in all
clusters, representing approx. half of all clustered genes
(see also additional file 1). As both increasing and decreas-
ing expression profiles showed enriched GOs in these
terms, we regarded these outcomes as a clear indication of
a changing flux through the cell-internal secretory path-
way, and with respect to the observed boost of the secre-
tory production of the heterologous protein IAP, as highly
valuable. Interestingly, the cluster of genes with the most
sensitive response towards the variation of the Pi supply
(cB2) was also enriched in the GO categories related to
carbohydrate metabolism. Considering the transcriptional
regulation of the insulin gene, which is under the regula-
tion of the glycolytic TPI1 promoter, this finding implies a
possible increase of the IAP transcript levels to be a cause
for its increased production under reduced phosphate
conditions.
In this study, additive information on transcriptional
changes was obtained when two different methodologies
were applied. Considering the consecutive expression
pattern of genes over the full range of the examined
phosphate levels proved to enrich the data derived from
a transient analysis of the transcriptional changes
among low (< 9.6 mM) versus high (> 22 mM) Pi levels.
As shown in (Figure 4A), both the pair-wise comparison
(DEA approach) and the regression based profile
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Figure 3 Identification of significant gene expression profiles in relation to the observed IAP expression dynamics. A. The insulin yield
on biomass, as a function of supplied phosphate. B. a heat map of the hierarchical clustering analysis based on genes picturing a significant
expression profile as a function of supplied phosphate; the lowest examined phosphate level [2.6 mM] was excluded from the SPA analysis; the
color code represents the scaled expression values. C.1. Two clusters cA1 (263 genes) and cA2 (202 genes) were selected, harboring genes with
declining expression profile with diminishing phosphate levels. The GO slim enrichment analysis identified each four categories, covering 66%
(cA1) and 74% (cA2) of genes within each cluster.C.2. Two clusters cB1 (115 genes) and cB2 (78 genes) were selected, harboring genes that
showed, similarly to the IAP yield, an increasing expression profile with decreasing phosphate levels. The GO slim enrichment analysis identified
three (cB1) and four (cB2) enriched categories, covering 65% (cB1) and 74% (cB2) of gene within each cluster, respectively.
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analysis (SPA approach) led to a complementary amount
of significant genes which supported the process of bio-
logical mining of the observed phenomena. Both, the
overlaps between down-regulated genes in the DEA
approach and the SPA derived clusters cA1 (1) and cA2
(11), and the up-regulated genes among the DEA
approach and the clusters cB1 (10) and cB2 (38), respec-
tively, represent the complementation of both
methodologies.
The impact of reduced phosphate supply on the
transcription of the insulin gene
For investigating the directed impact of the reduced Pi
supply to the target gene expression, we performed RT-
PCR experiments on both the transcripts of the insulin
gene (IAP) and for the TPI1 gene (TPI), as the regula-
tion of TPI1 was expected to have an impact on the
expression levels of insulin (same promoter). As sug-
gested by the gene ontology enrichment analysis, an
increased glycolytic activity was observed when cultures
were grown under low phosphate conditions [below
14.7 mM]. Although we identified relatively distinct
parts of carbohydrate metabolism to be differentially
regulated, i.e. glycerol biosynthesis (GPD2, HOR2) and
the down-stream part of glucose fermentation (PYK2,
PDC6, ADH1,4), we predicted the central node of these
two pathway branches within the glycolysis, encoded by
TPI1, to be affected in accordance.
The obtained transcript levels of the IAP and TPI1
were normalized to the levels found under high (33
mM) phosphate levels (Figure 4B). Both genes showed a
similar profile and significantly increased levels under
low Pi. In addition to our first conjecture that the
increased flux through the secretory pathways of the
cells benefits the heterologous insulin production, we
concluded that the elevated insulin production yields
observed under low phosphate are also enrooted on its
increased transcript levels.
Discussion
Under phosphate limiting conditions, the phosphate sig-
nal transduction (PHO) pathway is activated, leading to
a coordinated cellular response through a transcriptional
induction of a wide regulatory circuit, involving genes
coding for a high affinity transport system (PHO84,
PHO89), acid phosphatases (PHO5, PHO11, PHO12),
alkaline phosphatase (PHO8), polyphosphate storage
(PHM1 to PHM5), and genes involved in the catabolism
of alternative phosphorous sources (GIT1, GDE1,
HOR2) [14-16]. The actual activation of the PHO path-
way is triggered by the inhibition of the cyclin-depen-
dent kinase (CDK) complex Pho80-Pho85 via the CDK-
inhibitor Pho81 [17]. Very recently, it has been shown
that a small molecule ligand, inositol heptakisphosphate
Figure 4 Mining the impact of phosphate scarcity by using
complementary gene expression data sets. A. Venn diagram
representing the overlapping genes identified with the DEA
approach (comparison of cultures growing at low and high
phosphate levels) and the SPA approach (consecutive analysis of
gene expression patterns as a function of phosphate supply; gene
numbers with increasing expression at low phosphate (dark red)
and gene with decreasing expression at low phosphate (green) are
highlighted. B. RT-PCR analysis of the transcript levels of insulin
gene (blue) and the TPI1 gene (red) as a function of supplied
phosphate; increased levels of the IAP transcript were measured
under low phosphate levels; the mRNA levels are normalized to
their initial quantities at high phosphate levels [33 mM]; cultures
grown under limited phosphate supply [2.6 mM] showed decreased
IAP and TPI1 transcript levels.
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(IP7), is required for inducing the inhibitory activation of
Pho81 on the CDK complex [18], thereby preventing
that the kinase complex would hyperphosphorylate the
transcription factor Pho4. The unphosphorylated Pho4
can then associate with the nuclear importer receptor
Pse1 and translocate into the nucleus, and in coopera-
tion with another transcription factor Pho2, activate the
PHO-responsive genes [19].
Our data show a significant up-regulation of all named
high affinity phosphate transporters and acid phospha-
tases but one, being PHO5 (Figure 5, top right). It has
been shown that enzymes involved in inositol pyropho-
sphate synthesis appear to be essential for the regulation
of PHO5 expression [20]. In fact, KCS1, which has been
shown to suppress PHO5 expression under low phos-
phate conditions, is in this study more than three fold
up-regulated. Together with the two up-regulated genes
INM1 and PIS1 which are both encoding enzymes
further upstream in the inositol phosphate pathway, we
have an indication for the cross-talk of inositol pyropho-
sphate formation and PHO pathway activation. Evidence
of the cross-talk has also been found by [21], who
reported the cellular component stimulating the Pho81-
dependent inhibition of the CDK complex to be the
product of both IP6 kinases Kcs1 and Vip1. The implica-
tions of the non-differentially expression of PHO5 under
reduced phosphate concentrations for the design of
improved expression systems is significant. The PHO5
promoter has been a preferred regulator of heterologous
protein production, as cells which have been grown
under phosphate limitation over-express this acid phos-
phatase gene and consequently the heterologous protein
that has been put under the inducible PHO5 promoter
[22,23]. Our data underlines the benefit of using the
non-inducible TPI1 promoter, as the expression of the
target protein was positively affected by the reduction of
the phosphate level in the media through-out the exam-
ined phosphate range, whereas the a PHO5-dependent
expression would most likely show a benefit only at lim-
iting but not reduced phosphate levels.
Interestingly, when the phosphate concentration in the
medium is decreased, polyphosphate accumulation in
the vacuoles mediated by the vacuole transporter cha-
perone (VTC) complex, of which the four sub-units are
Figure 5 A schematic view on the inter-connection of cellular responses during growth on low phosphate levels. All labeled genes (left
hand side) and illustrated proteins (right hand side) showed significantly up-regulated transcript levels when cells were grown under low
phosphate levels [9.6 mM]. The up-regulated pathways included the glycerol biosynthesis (orange background), the lower part of glucose
fermentation, being significantly increased downstream from the pyruvate decarboxylation step (blue background), the phosphatidylinositol
biosynthesis and the lower part of inositol phosphate biosynthesis pathways (green background), yielding in heptakisphosphate (IP7) which has
been shown to regulate the inhibitory activity of Pho81, thus allowing the transcription factor Pho4 to access the nucleus and induce the PHO
pathway. Metabolites: Glc glucose, G6P glucose-6-phosphate, F1, 2 bP fructose-1,2-bisphosphate, DHAP dihydroxyacetone, Gro-3-P glycerol-3-
phosphate, GAP glyceraldehyde-3-phosphate, AcAld acetaldehyde, Ino-3-P inositol-3-phosphate, PI phosphatidylinositol, IP3 inositol triphosphate,
IP7 inositol heptakisphosphate, GroPIns glycerophosphoinositol, LPA lyso-phosphatidic acid.
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encoded by PHM1 to PHM4 (alias VTC1-4), was 2-3
fold up-regulated (Figure 5, lower right). Although this
seems to be contradictory, as polyphosphates represent
a Pi reserve used during periods of Pi starvation [24],
the increased intracellular phosphate levels, mostly
obtained by the high-affinity phosphate uptake mediated
by Pho84, need to be stored as polyphosphates in the
vacuoles for avoiding possible negative feedbacks to the
uptake system. As reported by Ogawa and co-workers
[16], increased cell-internal Pi levels would lead to inhi-
bitory effects on Pho84, thus counter-acting the high-
affinity transport system.
Our data show that the inositol biosynthesis pathway
is partly up-regulated with decreasing phosphate con-
centration in the medium. As the inositol concentration
in the media was kept constant for all investigated
media formulations, and INO1, encoding the first and
rate-limiting enzyme in inositol biosynthesis, did not
show any significant differential expression, no indica-
tion of inositol limitation were found. Still, with the up-
regulation of INM1 and PIS1, we had indications that
the formation of phosphatidylinositol (PI) was increased
(Figure 5, green cloud). Being an essential lipid for
eukaryotic cells, PI acts as a precursor for sphingolipids,
polyphosphoinositides, and most interestingly for glycer-
ophosphoinositol (GroPIns). The latter is derived trough
deacylation via phospholipases like PLB2, which in turn
was also up-regulated. It has been shown that GroPIns,
as a major PI catabolite in inositol containing medium,
is released to the extra-cellular milieu [25]. Under both
phosphate and inositol limiting conditions, GroPIns can
be transported into the cells, mediated by a permease
encoded by the GIT1 gene [26]. This permease gene
was found to be more than 17 fold increased and
among the top five genes we identified in this study to
be significantly differentially expressed in the pair-wise
comparison of high vs. low Pi. Our data underline the
outcomes of [27] who have reported an accumulation of
GIT1 transcripts when phosphate limitation is artificially
imposed in a Δpho85 strain. The findings are also in
accordance with Almaguer et al. [28] who also have
reported that GIT1 transcript levels and Git1p activity
are higher in cells starved for phosphate with or without
inositol limitation. The latter study also concludes that
GroPIns can act as the sole phosphate source for cells.
Both the physiological and the transcriptional changes
observed in this study suggest a carbon flux re-distribu-
tion within the glycolysis towards increased glycerol for-
mation. The increased transcript levels of GPD2, a
NAD-dependent glycerol-3-P dehydrogenase, and
HOR2, a glycerol-3-P phosphatase, (Figure 5, orange
cloud) lead to a more than 30 fold increase of the extra-
cellular glycerol (Figure 1C). Interestingly, GPD2 and
HOR2 are known to be induced under anaerobic
conditions and hyperosmotic stress, respectively [29],
yet these are not the conditions of our study. However,
it has been reported that the GPD2 transcript levels
respond to fluctuations of the cytosolic NADH/NAD+
ratio and thus to the redox state of the cytosol [30]. In a
recent study committed by Lu et al. [31], it has been
shown that components of the PHO pathway play
important roles in NAD+ metabolism. It has been
reported that low Pi conditions cause increased intracel-
lular nicotinamide riboside (NmR) levels, which are
derived through the catalysis of nicotinamid nucleotids
(NMR) by the alkaline phosphatase Pho8, leading to a
release of phosphate. We found that the transcript of
URH1, a key enzyme in the NmR-derived NAD+ bio-
synthesis, is increased with decreasing Pi supply. Taken
together with the increased flux through the NAD-
requiring glycerol biosynthesis, these outcomes under-
line the cross-talk between phosphate signaling and
NAD+ metabolism. Also, the conversion of glycerol-3-P
to glycerol leads to a gain of free phosphate and can
hence be considered as a possible reason for the up-reg-
ulation of this pathway. Still, a clear impact of reduced
phosphate on the glycolytic flux remains to be investi-
gated on a level that was beyond the scope of our study.
The determination of activities of the corresponding gly-
colytic enzymes and the determination of their Ks values
with respect to different phosphate levels could possibly
increase the fundamental understanding with respect to
the inter-dependency of glycolytic flux and phosphate
supply.
The SPA approach identified gene clusters with both
decreased (cA1 and cA2) and increased (cB1 and cB2)
expression pattern under reduced phosphate supply for
the enriched category of protein folding, modification
and transport. This category was further divided in dis-
tinct sub-groups for biological processes which are
related to general protein maturation, based on their
GO classifications. Four significantly enriched gene sets,
i.e. sub-categories that include genes with distinct roles
within the protein processing pathway, were identified.
We found that genes involved in ubiquitin-dependent
protein catabolism and in transport from ER to Golgi
were down-regulated under reduced phosphate supply,
whereas genes involved in cell wall organization and
biosynthesis and in Golgi vesicle-mediated transport
were up-regulated. These observations suggest that the
later secretory processing capacity of the cells (post-
Golgi) was enhanced while the retention-and possibly
the quality control-of proteins in the ER was reduced
when cells were cultures under reduced phosphate
concentrations.
It was also found that both the IAP expression under
the control of the TPI1 promoter and the TPI1 tran-
script levels increased with decreasing phosphate
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supply. To our knowledge, the transcriptional up-regu-
lation of TPI1 as a consequence of reduced phosphate
supply has not been reported before. We would like to
stress the possibility that the increased IAP transcript
levels could also be derived from an increased amplifi-
cation level of the expression cassette (2 μplasmid)
harboring the IAP gene, suspecting an increased gene
dosage of IAP to cause higher transcript levels. Yet,
due to the increase of the transcript level of the geno-
mic TPI1 and its similar trend to the IAP transcript,
we consider TPI1 to be transcriptionally regulated by
the phosphate supply. Finally, our DEA approach
showed a moderate up-regulation of the transcription
factor GCR1 (1.7 fold), which is known to regulate the
high-level expression of TPI1 [32]. Although transcrip-
tion factors are generally believed to be regulated post-
transcriptionally, the increased transcription of GCR1
is in accordance to our finding regarding the TPI1
expression dependency on phosphate availability, and
thus can be considered as a possible reason for the up-
regulation of TPI1. Still, the increased transcription of
IAP cannot be considered as the sole reason for the
increased secretory production of IAP. The initial
decrease of Pi from [33 mM] to [14.7 mM] did not sig-
nificantly affect the transcript levels of IAP (increase of
6.9% with a SD of 3.6%), yet the yield of secreted IAP
increased 22.6%, suggesting that the global increase of
the secretory flux, i.e. the increased secretion of diverse
phosphatases and high affinity phosphate transporters,
did also benefit the secretory production of IAP. In
follow-up studies, and for separately addressing the
impact of reduced phosphate supply on both the tran-
scription and the secretion of a heterologous protein,
the glycolytic TPI1 promoter should be replaced with a
non-glycolytic promoter, e.g. TEF1, as by de-coupling
the two identified conjectures for improved IAP secre-
tion found in this study, more explicit conclusions
would be promoted
As TPI1 is one of the most commonly used glycolytic
promoters for recombinant expression of diverse hetero-
logous proteins in yeast, our data suggests that a special
care needs to be taken with the design of the growth
media with respect to phosphate supply. For most com-
monly used media for laboratory scale studies, e.g. deri-
vatives of [33], supply a high amount of phosphate to
ensure optimal conditions for biomass formation. The
supplied P/C ratio of 0.4 (mM phosphate per mM glu-
cose) is 8 fold higher than the starting P/C ratio we
used in this study (0.05). In addition, we report that a
two fold gain of cell specific productivity and 25%
increase of volumetric productivity can be achieved by
further decreasing the phosphate supply to at least half
of the initial concentration.
Conclusions
In the present study, we looked into the physiological
impacts of phosphate shortage in an industrial API pro-
duction process. We identified a positive effect of
reduced phosphate supply on the secretory production
of human insulin in S. cerevisiae. The cellular response
towards reduced phosphate levels in the medium was
pictured in the up-regulation of multiple phosphatases
and permeases that are channeled towards the extracel-
lular space, thus leading to an increased activity of the
protein trafficking pathway. By following the successive
response of reduced phosphate levels on the physiologi-
cal state of cells, we identified a range of interest for
improved IAP productivity, covering low but not critical
Pi levels. The consecutive methodology we applied for
studying the regulatory shifts from cells growing under
carbon limitation towards phosphate limitation resulted
in more profound insights into the adaptive response of
the cells to their nutrient availability. By combining
information obtained through the analysis of differen-
tially expressed genes among low and high phosphate
levels, with the identification of significant gene expres-
sion patterns which followed major phenotypic observa-
tions, e.g. IAP productivity, we enlarged the picture of
cellular events during growth on reduced phosphate
levels.
Our work underlines the inter-connection among the
signaling of phosphate scarcity, the re-distribution of
glycolytic flux towards glycerol and ethanol production,
the phosphatidylinositol biosynthesis, the NAD bio-
synthesis, and the polyphosphate metabolism. Moreover,
we emphasize the importance of optimized media for-
mulation with respect to a reduced P/C ratio, aiming at
improved heterologous protein production. We con-
clude that a dietary supply of phosphate can potentially
enhance the secretory production of a heterologous pro-
tein. Under reduced phosphate levels, the usage of the
glycolytic TPI1 promoter further increased the recombi-
nant transcript levels of the IAP gene, advancing the
overall productivity of the target protein.
Methods
Expression backbone
The haploid S. cerevisiae strain CEN.PK113-11C (MATa,
ura3-52 his3-D1, MAL2-8c SUC2) was transformed with
the URA3d based expression cassette pU17 via LiAc
method, according to [34]. The 2 micron vector pU17 is a
HIS3 plasmid derived from [35], with an expression cas-
sette containing the TPI1 promoter and the insulin analo-
gue precursor (IAP) gene that encodes an insulin AspB28
molecule where the A- and B-chain are connected by a
EWK C-peptide [36]. The secretory expression of the insu-
lin precursors was performed with the aid of the mating
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type factor alpha leader in the configuration: a-factor lea-
der-KR-spacer-insulin precursor, leading to an optimized
processing of the fusion protein by the native Kex2 endo-
protease, as described by [37]. The expression cassette also
contains the URA3 open reading frame plus 17 base pairs
of the endogenous URA3 promoter. Both HIS3 and URA3
were used as auxotrophic selection markers. The URA3d
based plasmids provide an increased pool of the recombi-
nant gene (IAP) as the defective URA3 gene led to ampli-
fied plasmid copy numbers (Kazemi Seresht et al., in
preparation).
High cell density cultivation
The batch phase was followed by a carbon-limited fed-
batch phase with an open loop controlled specific growth
rate of μset = 0.1 h
-1. During this phase, 55 gL-1 glucose
was added to the process (feed concentration 500 gL-1).
The fed batch phase was automatically initiated after glu-
cose depletion during the batch phase, monitored and
controlled with the decrease of the carbon dioxide signal
in the off-gas measurement. The chemostat phase was
automatically initiated after the fed batch phase. The cul-
ture volume was controlled via a gravimetric feed control,
ensuring a fixed dilution rate of D = 0.1 h-1. The respira-
tory quotient (RQ) and the at-line analysis of ethanol in
the exhaust gas were monitored, confirming a fully
respiratory growth of the cells during the fed batch and
chemostat phases, i.e. the chosen dilution rate was lower
than the critical dilution rate and no ethanol formation
was detected. The pH was controlled at 5.9 by addition
of NH4OH (10%), which provided a non-limiting nitro-
gen source throughout the whole process. The tempera-
ture was controlled at 28°C, and the dissolved oxygen
tension (DOT) was kept above 40% of saturation to avoid
oxygen limitation. Cultivations were performed in the
Sartorius Stedim Biotech BIOSTAT Qplus® (0.4 L scale).
Media formulation
The defined growth medium for plates was 6.7 gl-1 yeast
nitrogen base without amino acids, but with ammonium
sulphate, 2% glucose, 2% agar and the relevant CSM
drop-out amino acid mixture (from Qbiogene). A
defined minimal medium (DMM) was used in all experi-
ments. Its basal composition for pre-cultures (5 mL
scale in 50 mL falcon tubes) and shake flasks (100 mL
scale in 500 mL shake flasks with two baffles) was: 10.5
gL-1 Potassium hydrogen phthalate (KHP), 5 gL-1 (NH4)
2SO4, 2 gL
-1 KH2PO4, 0.5 gL
-1 MgSO4·7 H2O, 0.1 gL
-1
CaCl2·2 H2O, 100 μLL
-1 antifoam (Antifoam 204,
Sigma-Aldrich), 1 mLL-1 trace metals solution, 1 mLL-1
vitamin stock solution, and an initial glucose concentra-
tion of 20 gL-1. The trace metal and vitamin solutions
were derived from [33]. For chemostat experiments, a
modified DMM was used with the following
composition: 3 gL-1 KH2PO4, 2 gL
-1 (NH4)2SO4, 1.5 gL
-1
MgSO4·7 H2O, 0.2 gL
-1 CaCl2·2 H2O, 0.1 gL
-1 NaCl, 200
μLL-1 antifoam, 10 mLL-1 trace metals solution, 10
mLL-1 vitamin stock solution. The initial glucose con-
centration in the batch was set to 20 gL-1, and in the
chemostat medium to 75 gL-1. Cultivations were carried
out under six different phosphate concentrations, using
KH2PO4 as phosphate source (Table 1). The resulting
alternations in the potassium (K) levels were compen-
sated for by addition of KCl.
Microarray analysis
Sampling method
Samples for RNA isolation were taken during the steady
state phase of the cultivations. Three samples were with-
drawn within 48 hours and used as biological replicates
for each culture. For the sampling, 5 mL culture broth
were rapidly taken into a 50 mL sterile Falcone tube, pre-
filled with 25 mL of crushed ice, in order to decrease to
sample temperature to below 4°C in a few seconds. Cells
were centrifuged (4000 rpm at 0°C for 2 min.), the super-
natant discarded, the pellet was frozen in liquid nitrogen
and stored at -80°C, and the RNA extraction was per-
formed within a month. Total RNA was extracted using
the Ambion RiboPure Yeast Kit (Applied Biosystems,
Austin, USA), according to manufacturer’s instruction,
after thawing the cell pellets on ice. RNA sample integrity
was determined with an Agilent 2100 Bioanalyzer and
RNA 6000 Nano LabChip kit (Agilent, Santa Clara, CA),
ensuring RIN values above 9.0, and total RNA quantity
was determined with a NanoDrop 3300 UV-Vis spectro-
photometer (Thermo Scientific, Rockford, USA).
Microarray analysis and data acquisition
Using the 3’IVT Expression Kit (One-Cycle cDNA
Synthesis) and the GeneChip Hybridization, Wash and
Stain Kit, the probe preparation and hybridization to
Affymetrix Yeast Genome Y2.0 arrays were performed
according to manufacturer’s instructions (Affymetrix
GeneChip Expression Analysis Technical Manual, P/N
702232, Rev.2). Washing and Staining of arrays were
performed using the GeneChip Fluidics Station 450 and
Table 1 The addition of different concentrations of
KH2PO4 and KCl to DMM, for alternating the phosphate
levels and maintaining the potassium levels, respectively.
Pi conc.
[culture ID]
KH2PO4 in DMM
[gL-1]
KCL in DMM
[gL-1]
33 mM 4.5 -
22 mM 3.0 -
14.7 mM 2.0 0.6
9.6 mM 1.3 1.0
5.5 mM 0.75 1.3
2.6 mM 0.35 1.5
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scanning with the Affymetrix GeneArray 3000 7G Scan-
ner (Affymetrix, Santa Clara, CA). The Affymetrix Gen-
eChip Command Console Software (AGCC) was used to
generate CEL files of the scanned arrays. Data analysis
was performed using the statistical open source lan-
guage R (R Development Core Team, http://www.r-pro-
ject.org), supplemented with Bioconductor v2.8
(Bioconductor Core Team, http://www.bioconductor.
org). Data preprocessing was carried out by using the
Robust Multichip Average method, considering the cal-
culated probe affinity derived from position dependent
base effects (GC-RMA), including a quantile normaliza-
tion of probe intensities and a median polishing step for
expression measure calculation.
Gene Expression Analysis
For the Differential Expression Analysis (DEA), the Lin-
ear Models for Microarray Data (LIMMA) method was
applied, using the limma statistical package. A moder-
ated t-test between the two experiment sets of low (9.6
mM Pi) and high (22 mM Pi) phosphate supplemented
cultures was used for pair-wise comparison. Empirical
Bayesian statistics were used to moderate the standard
errors within each gene and Benjamini-Hochberg’s
method was applied to adjust for multiple testing. A
cut-off value of adjusted p < 0.05 was chosen for statisti-
cal significance. The statistically significant differential
gene expression list was further trimmed by considering
only genes with |fold change| > 2 as biological signifi-
cant. Significant gene ontology (GO) process terms of
the selected genes were identified using GO Slim Map-
per tools (Saccharomyces Genome Database SGD) with
a threshold of p < 0.01.
For the Significant Profile Analysis (SPA), the Micro-
Array Significant Profiles (maSigPro) method was
applied, using the masigpro statistical package. A two-
step linear regression model was used to identify genes
with a significant expression profile as a response to
alternating phosphate supply, considering gene sets of
five different cultures growing at 5.5 mM, 9.6 mM, 14.7
mM, 22 mM, and 33 mM phosphate concentration in
the feed reservoir. The step-wise regression was adjusted
to polynomial degree of 2, a significance cut-off of a =
0.05 was used, and an R-squared cut-off of 0.7 was cho-
sen to increase the goodness of the fit. The identified
significant gene set was clustered in 10 subsets using a
hierarchical clustering method. A similar GO enrich-
ment analysis as for the DEA approach was applied to
the identified gene subsets
Analytical methods
Extracellular metabolites
The extra-cellular metabolites glucose, glycerol, acetate,
and ethanol were analyzed on a reverse phase HPLC
(Agilent 1200), separated on a Rezex ROA-organic acid
H+ (8%) 7.8 × 300 mm column (Phenomenex), operat-
ing at 45°C and at a flow rate of 0.5 mLmin-1, using a 5
mM H2SO4 solution as running buffer. Detection was
done using a refractive index detector.
Human insulin
Insulin was separated on a reverse phase HPLC (Agilent
1200) on a C4 Jupiter 4.6 × 250 mm (5 μm) column
(Phenomenex), operating at 42°C and at a flow rate of 1
mLmin-1. Buffer A was composed of 0.1% TFA in milliQ
water, and buffer B was composed of 0.07% TFA in
acetonitrile, with an elution gradient of 20-80% B in 20
minutes, 100% B in 5 minutes, 100-20% B in 0.1 min-
utes. The UV-detection was performed at 214 nm, and
the concentration was determined using Human Insulin
as external standard.
RT-qPCR
Total RNA was extracted using the Ambion RiboPure
Yeast Kit (Applied Biosystems, Austin, USA), according
to manufacturer’s instructions. The RNA extracts were
treated with DNAse (TURBO DNAse, Ambion), and the
RNA concentration was measured with a Spectrophot-
ometer (Nanodrop 3300®, Thermo Scientific). For cDNA
synthesis, the High Capacity cDNA Reverse Transcrip-
tion Kit (Applied Biosystems) was used. Quantification of
the cDNA levels of the insulin gene (IAP), ACT1 and
TPI1 was performed by quantitative PCR using a Strata-
gene MX3005p® instrument. ACT1 was used as reference
gene, with the primer set 5’-GCCTTCTACGTTTC-
CATCCA-3’ and 5’-GGCCAAATCGATTCTCAAAA-3’.
Transcript levels were determined for the IAP gene,
using the primer set 5’-GAAGCTGAAGCTC-
CAAAGTTCG-3’ and 5’-CGGGCTGCGTCTAGTTA-
CAGTAG-3’, and for TPI1, using the primer set 5’-
TCCCAGAAAATGTCGAAGTTG-3’ and 5’-
GGCTTCTTAACCAAAGAGACAGA-3’. Standard
curves were generated pooled cDNA from all samples,
and efficiencies close to 100% were achieved (E ≥ 95%).
Potential primer dimerization effects were excluded via
melting curve analysis.
Calculations of yields and productivities
All yield and productivity calculations are based on
averaged concentrations of the corresponding com-
pound, derived from samples that were taken during the
steady state phase of cultivations. The biomass yield is
represented as yX/S and based on the mass of consumed
glucose (g/g), whereas the yield of the metabolites etha-
nol and glycerol are represented as YE/S and YG/S and
based on the molar mass of consumed glucose (mmol/
mol), respectively. The insulin production yield yIAP/X is
based on the cell dry weight (mg/g). The specific insulin
productivity qIAP/X is defined as the product of the dilu-
tion rate (D) and insulin production yield (yIAP/X) during
the steady state phase of chemostat cultivations.
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Additional material
Additional file 1: Sum-up of the GO Slim enrichment analysis. A
detailed illustration of the GO Slim enriched categories of clusters cA1
(page 1), cA2 (page 2), cB1 (page 3), and cB2 (page 4) is shown as
presented in Figure 3.
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